Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated
<b>Background/Objective:</b> Millions of children were infected with SARS-CoV-2, and a small proportion progressed to severe disease, especially those with underlying risk factors. Adult COVID-19 studies showed mortality benefits with Remdesivir. Data on Remdesivir use in pediatrics are limited. We...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2025-03-01
|
| Reeks: | Children |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2227-9067/12/3/331 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|